Vivos Therapeutics (NASDAQ:VVOS) reported quarterly losses of $(0.26) per share. This is unchanged from the same period last year. The company reported quarterly sales of $4.25 million which beat the analyst consensus estimate of $3.72 million by 14.14 percent. This is a 6.60 percent decrease over sales of $4.55 million the same period last year.
CORRECTION: Vivos Therapeutics Q3 EPS $(0.26), Same YoY, Sales $4.25M Beat $3.72M Estimate
Vivos Therapeutics (NASDAQ:VVOS) reported quarterly losses of $(0.26) per share. This is unchanged from the same period last year. The company reported quarterly sales of $4.25 million which beat the analyst consensus
